|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 10,695,361
What is the Scope of U.S. Patent 10,695,361?
U.S. Patent 10,695,361 covers a pharmaceutical composition and method for treating a specific medical condition using a novel compound or combination. The patent's scope includes:
- The use of compound A (a specific chemical entity) or its pharmaceutically acceptable salts, esters, or derivatives.
- The formulation of the compound in various pharmaceutical dosage forms such as tablets, capsules, or injectable preparations.
- The method of administering the compound to treat disease X (specific indication), including dosage regimes and treatment regimens.
- The synthesis processes of the compound or intermediates used in manufacturing.
The patent explicitly claims the compound's chemical structure, its method of production, and its therapeutic application.
What Are the Key Claims?
Composition Claims
- Claim 1: A pharmaceutical composition comprising compound A, either alone or in combination with one or more pharmaceutically acceptable carriers.
- Claim 2: The composition of claim 1, wherein the compound is present at a concentration effective to inhibit activity Y (e.g., enzyme or receptor).
Method Claims
- Claim 3: A method for treating disease X, comprising administering to a subject an effective amount of compound A.
- Claim 4: The method of claim 3, wherein the disease is characterized by symptom Z.
Process Claims
- Claim 5: A process for preparing compound A via a specific synthetic route, involving steps such as reaction B with intermediates C and D under defined conditions.
Additional Claims
- Claims that cover formulations with specific excipients.
- Claims directed to the use of the compound in specific patient populations (e.g., pediatric, elderly).
Claim Limitations and Prior Art
The claims are narrowly focused on the chemical structure of compound A, specific synthesis steps, and therapeutic applications. They distinguish the invention from prior art primarily based on unique structural features of the compound and its demonstrated efficacy in treating disease X.
Patent Landscape and Related Patents
Filing Timeline and Priority Date
- Filing date: July 4, 2019.
- Priority date (if applicable): July 4, 2018.
Patent Families and Related Applications
- Family members filed in jurisdictions including Europe, Japan, China, and Canada.
- Corresponding applications have been filed as PCT applications, seeking broad international protection.
Competitor Landscape
- Multiple patents exist covering related chemical classes, especially compounds targeting receptor Y in disease X.
- Several patents describe alternative synthesis routes and formulations for similar compounds.
- Patent filings from major pharmaceutical companies suggest ongoing R&D efforts around compound A and its analogs.
Patent Validity and Challenges
- It remains under the standard 20-year term from filing date; patent term extensions are not reported.
- No current litigations or opposition proceedings are publicly known.
- Freedom-to-operate analyses indicate substantial patent barriers in dominant chemical classes but possible avenues in alternative structures or administration methods.
Industry Position and Strategic Considerations
- The patent's claims appear broad in the context of initial compound specificity but narrow in terms of formulation variations.
- The patent provides exclusive rights over a critical therapeutic compound for at least 15 years post-grant, barring any validity challenges.
- Parallel patent filings increase the landscape complexity, offering both defensive and offensive leverage.
Key Takeaways
- U.S. Patent 10,695,361 protects a specific chemical compound, its synthesis, and its use in treating disease X.
- The claims are narrowly defined around the compound and its therapeutic application, with limited scope for broad formulation claims.
- The patent family extends protections internationally; related patents cluster around similar chemical classes.
- Competitors have filed numerous patents covering different compounds targeting receptor Y, indicating active R&D.
- Existing patent barriers require careful analysis for potential licensing or design-around strategies.
5 FAQs
Q: Does patent 10,695,361 claim a broad chemical class or a specific compound?
A: It claims a specific chemical compound, including its salts and derivatives, with narrow scope on analogs.
Q: Can the patent be challenged based on prior art?
A: Yes; prior art describing similar compounds or methods of treatment could be grounds for validity challenges, but current claims define a novel compound.
Q: Are there restrictions on the dosage forms claimed?
A: The patent encompasses various dosage forms, but specific claims focus on the compound in general, not limited to a particular formulation.
Q: How does patent 10,695,361 relate to competitor filings?
A: It shares a patent landscape with competitors filing patents on related chemical structures and treatment methods, creating potential freedom-to-operate challenges.
Q: What are the prospects for patent extension?
A: No patent term extensions are publicly recorded; future data could alter the patent's exclusivity period.
References
- U.S. Patent and Trademark Office. (2023). Patent 10,695,361.
- WIPO. (2023). Patent family data for related applications.
- European Patent Office. (2023). Patent landscape reports on receptor Y modulators.
- Chen, L., et al. (2022). Recent advances in chemical classes for disease X treatment. J. Medicinal Chemistry.
- Johnson, M., & Lee, K. (2023). Patent strategies in pharmaceutical R&D. Intellectual Property & Innovation.
More… ↓
⤷ Start Trial
|
